On Tuesday, Heron Therapeutics Inc (NASDAQ: HRTX) opened lower -4.09% from the last session, before settling in for the closing price of $2.20. Price fluctuations for HRTX have ranged from $1.04 to $3.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.88% over the last five years. Company’s average yearly earnings per share was noted 50.00% at the time writing. With a float of $151.00 million, this company’s outstanding shares have now reached $152.13 million.
The firm has a total of 122 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.71%, operating margin of -7.5%, and the pretax margin is -8.83%.
Heron Therapeutics Inc (HRTX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Heron Therapeutics Inc is 0.87%, while institutional ownership is 75.71%.
Heron Therapeutics Inc (HRTX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.00% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Check out the current performance indicators for Heron Therapeutics Inc (HRTX). In the past quarter, the stock posted a quick ratio of 1.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach 0.05 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Analysing the last 5-days average volume posted by the [Heron Therapeutics Inc, HRTX], we can find that recorded value of 0.88 million was lower than the volume posted last year of 1.75 million. As of the previous 9 days, the stock’s Stochastic %D was 10.91%. Additionally, its Average True Range was 0.15.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 65.24%, which indicates a significant increase from 2.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.24% in the past 14 days, which was lower than the 108.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.02, while its 200-day Moving Average is $2.06. Now, the first resistance to watch is $2.17. This is followed by the second major resistance level at $2.24. The third major resistance level sits at $2.27. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $2.04. Should the price break the second support level, the third support level stands at $1.97.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
There are currently 152,330K shares outstanding in the company with a market cap of 321.42 million. Presently, the company’s annual sales total 144,290 K according to its annual income of -13,580 K. Last quarter, the company’s sales amounted to 40,780 K and its income totaled 3,660 K.
